Inflammation, metaflammation and immunometabolic disorders
The DOI matches its Crossref record; 144 of the 144 references it cites were found in a registry or an index.
Abstract
Proper regulation and management of energy, substrate diversity and quantity, as well as macromolecular synthesis and breakdown processes, are fundamental to cellular and organismal survival and are paramount to health. Cellular and multicellular organization are defended by the immune response, a robust and critical system through which self is distinguished from non-self, pathogenic signals are recognized and eliminated, and tissue homeostasis is safeguarded. Many layers of evolutionarily conserved interactions occur between immune response and metabolism. Proper maintenance of this delicate balance is crucial for health and has important implications for many pathological states such as obesity, diabetes, and other chronic non-communicable diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypertrophic visceral adipose tissue is a primary driver of chronic, low-grade meta-inflammation, characterized by an accelerated secretion of pro-inflammatory cytokines (such as TNF-alpha and IL-6) and a concomitant reduction in protective adiponectin [9,11,12].”
From Trimester-Specific Bioelectrical Impedance Reference Curves in Physiological Pregnancy: Mapping Maternal Body Composition and Hydration Trajectories (2026) · cites this paper as [9]
In the citing paper
“Excess visceral adiposity does not merely represent a passive energy reserve; rather, it acts as an active immunometabolic organ [8-10].”
From Trimester-Specific Bioelectrical Impedance Reference Curves in Physiological Pregnancy: Mapping Maternal Body Composition and Hydration Trajectories (2026) · cites this paper as [9]
In the citing paper
“Inflammageing is now being recognized as a hallmark of ageing and a key driver of disease (FIG. 3Aa), including ageing-associated diseases, and has been described as a prominent risk factor for morbidity and death95–97.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
In the citing paper
“Chronic inflammation has profound effects on systemic metabolism, via a complicated crosstalk between immune cells and metabolic cells, such as hepatocytes and adipocytes, influencing metabolic processes such as glucose and lipid uptake, and insulin sensitivity96.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
In the citing paper
“For example, in obese tissues such as the visceral fat, peripheral monocytes are recruited by stressed adipocytes, leading to a progressive infiltration of proinflammatory M1-like macrophages and the displacement of the resident, anti-inflammatory M2 macrophages96.”
From NAD+ metabolism and its roles in cellular processes during ageing (2021) · cites this paper as [96]
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Collino, M., Benetti, E., Rogazzo, M., Chiazza, F., Mastrocola, R., Nigro, D., Cutrìn, J. C., Aragno, M., Fantozzi, R., Minetto, M. A., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12888 · Cited by 25
RetractedObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
The metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
Genetic studies of body mass index yield new insights for obesity biology
Study, T. L. C., Locke, A. E., The ADIPOGen Consortium, The AGEN-BMI Working Group, The CARDIOGRAMplusC4D Consortium, The CKDGen Consortium, The, G. L. G. C., The, I. C. B. P., The MAGIC Investigators, The MuTHER Consortium, et al. (2015) · Nature · doi:10.1038/nature14177 · Cited by 4,534
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Cited by
Items 401–500 of 1,004
TLR9 in MAFLD and NASH: At the Intersection of Inflammation and Metabolism
Shepard, C. R. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.613639 · Cited by 64
Xu, J., Zheng, Y., Zhao, Y., Zhang, Y., Li, H., Zhang, A., Wang, X., Wang, W., Hou, Y., & Wang, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.817572 · Cited by 86
“Inflammation refers to the typical response of the host immune system to microbial infection or tissue injury (18, 19).”
BackgroundThe Epigenomic Analysis of Human Obesity
Bell, C. G. (2017) · Obesity · doi:10.1002/oby.21909 · Cited by 66
“Obesity induces changes in innate immune cells, increases CD4(1) and CD8(1) T cells, and reduces tolerance-promoting regulatory B cells, as well as inducing abnormal B cell function (64).”
BackgroundRahman, M. H., Bhusal, A., Lee, W., Lee, I., & Suk, K. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.01.024 · Cited by 61
Calle, M. C., & Andersen, C. J. (2019) · Disease Markers · doi:10.1155/2019/3102870 · Cited by 67
Current progress of mesenchymal stem cell membrane-camouflaged nanoparticles for targeted therapy
Fan, L., Wei, A., Gao, Z., & Mu, X. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114451 · Cited by 57
Frasca, D., Diaz, A., Romero, M., & Blomberg, B. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.616650 · Cited by 58
“Fat mass indeed increases with age in humans (43, 44) and this is associated with increased inflammaging (1), metabolic dysfunction (5, 45) and development of insulin resistance which also increases with age (46).”
BackgroundThe Importance of Metabolism for Immune Homeostasis in Allergic Diseases
Rodríguez‐Coira, J., Villaseñor, A., Izquierdo, E., Huang, M., Barker‐Tejeda, T. C., Radzikowska, U., Sokołowska, M., & Barber, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.692004 · Cited by 62
Wang, D., Jiang, S., Zhang, F., Ma, S., Heng, B. C., Wang, Y., Zhu, J., Xu, M., He, Y., Wei, Y. Q., et al. (2021) · Advanced Science · doi:10.1002/advs.202101562 · Cited by 62
Xu, M., Li, Y., Wang, X., Zhang, Q., Wang, L., Zhang, X., Cui, W., Han, X., Ma, N., Li, H., et al. (2022) · Environmental Health Perspectives · doi:10.1289/ehp9373 · Cited by 60
“A challenge to elucidating the mechanistic process of NAFLD is attributed to the sophisticated context of the tissue microenvironment in the liver, which comprises multiple cell types and extracellular matrix (Hotamisligil 2017).”
BackgroundPaine, A., Brookes, P. S., Bhattacharya, S., Li, D., García-Hernández, M. D. L. L., Tausk, F., & Ritchlin, C. T. (2022) · Arthritis & Rheumatology · doi:10.1002/art.42288 · Cited by 61
“This potential metabolic inflammation link (9) may provide opportunities to identify”
BackgroundEmerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
Lasorsa, F. M., di Meo, N. A., Rutigliano, M., Ferro, M., Terracciano, D., Tătaru, O. S., Battaglia, M., Ditonno, P., & Lucarelli, G. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020910 · Cited by 63
“Further future studies will be necessary to unravel molecular mechanisms linking aberrant metabolism and cancer [9,10].”
BackgroundVella, V., Lappano, R., Bonavita, E., Maggiolini, M., Clarke, R. B., Belfiore, A., & Francesco, E. M. D. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad005 · Cited by 62
White Adipose Tissue Dysfunction: Pathophysiology and Emergent Measurements
Santillana, N., Astudillo-Guerrero, C., D’Espessailles, A., & Cruz, G. (2023) · Nutrients · doi:10.3390/nu15071722 · Cited by 70
“Unhealthy AT expansion and, consequently, metaflammation leads to an impairment in insulin signaling pathways in the adipocyte, thus decreasing its capacity to store energy [38].”
BackgroundRejeski, K., dos Santos, D. M. C., Parker, N. H., Bücklein, V., Winkelmann, M., Jhaveri, K. S., Liu, L., Trinkner, P., Günther, S., Karschnia, P., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0487 · Cited by 63
“Adipose tissue may also exert pro-immunogenic anti-lymphoma effects via meta fl ammation (50).”
Zhou, J., Ding, L., Chen, W., & Wang, Y. (2023) · Food Frontiers · doi:10.1002/fft2.252 · Cited by 61
Impact of NAD+ metabolism on ovarian aging
Liang, J., Huang, F., Song, Z., Tang, R., Zhang, P., & Chen, R. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00398-w · Cited by 63
“The relationship between chronic inflammation, immune cells, and metabolic cells is complex [209].”
BackgroundAntidiabetic drug glyburide modulates depressive-like behavior comorbid with insulin resistance
Su, W.-J., Peng, W., Gong, H., Liu, Y.-Z., Zhang, Y., Lian, Y.-J., Cao, Z.-Y., Wu, R., Liu, L.-L., Wang, B., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0985-4 · Cited by 54
“Treating rodent diabetic models with anti-IL-1β therapy resulted in ameliorated insulin insensitivity as well as improved β-cell survival [15].”
Visceral Adipose Tissue Accumulation and Residual Cardiovascular Risk
Jemtel, T. H. L., Samson, R., Milligan, G. P., Jaiswal, A., & Oparil, S. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0880-0 · Cited by 61
Influence of Obesity on Pneumococcus Infection Risk in the Elderly
Frasca, D., & McElhaney, J. E. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00071 · Cited by 64
“This occurs through metaflammation (27) in which excess nutrients, due to inefficient glucose metabolism, promote chronic low-grade inflammation.”
BackgroundDeep Brain Stimulation for Obesity: A Review and Future Directions
Formolo, D. A., Gaspar, J. M., Melo, H. M., Eichwald, T., Zepeda, R. J., Latini, A., Okun, M. S., & Walz, R. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00323 · Cited by 61
“All of these factors are involved in the induction of systemic inflammation which can result in changes in metabolic and endocrine signaling (Hotamisligil, 2017).”
BackgroundYu, L., Lǐ, Y., Du, C., Zhao, W., Zhang, H., Yang, Y., Sun, A., Song, X., & Feng, Z. (2019) · Mediators of Inflammation · doi:10.1155/2019/5271295 · Cited by 61
“Circulating levels of FAs are significantly higher in obese compared with lean individuals, which results in increased TLR4 signaling in obesity and inflammation [101, 103].”
Backgroundvan den Hoek, A. M., de Jong, J. C. B. C., Worms, N., van Nieuwkoop, A., Voskuilen, M., Menke, A. L., Lek, S., Caspers, M. P. M., Verschuren, L., & Kleemann, R. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154873 · Cited by 53
Appetite Regulation of TLR4-Induced Inflammatory Signaling
Li, Y., Jiang, Q., & Wang, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.777997 · Cited by 63
“Therefore, TLR4induced inflammatory signaling provides a mechanistic link between the hypothalamus, mesolimbic dopamine (DA) system and appetite (6).”
BackgroundImpaired phosphocreatine metabolism in white adipocytes promotes inflammation
Maqdasy, S., Lecoutre, S., Renzi, G., Frendo‐Cumbo, S., Rizo‐Roca, D., Möritz, T., Juvany, M., Hodek, O., Gao, H., Couchet, M., et al. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00525-9 · Cited by 59
“From these results in human white adipocytes, we conclude that (1) CKB is the most highly expressed CK, (2) CK-B resides in the cytosol and (3) CK-B downregulation results in increased cellular phosphocreatine/creatine ratio.”
ResultRecent Discoveries on Marine Organism Immunomodulatory Activities
Montuori, E., de Pascale, D., & Lauritano, C. (2022) · Marine Drugs · doi:10.3390/md20070422 · Cited by 60
“However, uncontrolled and prolonged inflammatory responses are harmful to the host and promote the pathogenesis of many inflammatory diseases, such as metabolic disorders [17].”
BackgroundVesicular Antibodies: Shedding Light on Antibody Therapeutics with Cell Membrane Nanotechnology
Zhao, C., Pan, Y., Yu, G., Zhao, X., Chen, X. S., & Rao, L. (2023) · Advanced Materials · doi:10.1002/adma.202207875 · Cited by 60
Physiopathological mechanisms related to inflammation in obesity and type 2 diabetes mellitus
Lempesis, I. G., & Georgakopoulou, V. (2023) · World Journal of Experimental Medicine · doi:10.5493/wjem.v13.i3.7 · Cited by 67
Quantification of Bone Fatty Acid Metabolism and Its Regulation by Adipocyte Lipoprotein Lipase
Bartelt, A., Koehne, T., Tödter, K., Reimer, R., Müller, B., Behler-Janbeck, F., Heeren, J., Scheja, L., & Niemeier, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061264 · Cited by 56
“In the context of obesity, the capacity of these stores is exhausted, and consequent improper lipid handling leads to inflammation and insulin resistance, promoting the development of metabolic diseases such as type 2 diabetes and atherosclerosis [3].”
BackgroundA Receptor of the Immunoglobulin Superfamily Regulates Adaptive Thermogenesis
Hurtado del Pozo, C., Ruiz, H. H., Arivazhagan, L., Aranda, J. F., Shim, C., Daya, P., Derk, J., MacLean, M., He, M., Frye, L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.061 · Cited by 54
“Selective pressures in evolution favor phenotypes that safeguard survival in the face of paucities and extreme stresses (Hotamisligil, 2017).”
Diez‐Echave, P., Vezza, T., Rodríguez‐Nogales, A., Ruiz‐Malagón, A. J., Hidalgo‐Garcia, L., Garrido‐Mesa, J., Molina‐Tijeras, J. A., Romero, M., Robles‐Vera, I., Pimentel-Moral, S., et al. (2019) · Food Research International · doi:10.1016/j.foodres.2019.108722 · Cited by 59
Frasca, D., Reidy, L. J., Romero, M., Diaz, A., Cray, C., Kahl, K. W., & Blomberg, B. B. (2021) · International Journal of Obesity · doi:10.1038/s41366-021-01016-9 · Cited by 54
“These antibodies were found to be significantly lower in obese as compared to lean COVID-19 patients, confirming our previously published findings that BMI is negatively associated with anti-Spike IgG serum levels [19] and consistent with the knowledge that obesity is associated with inflammaging [2] and metaflammatio…”
ResultGPSM1 impairs metabolic homeostasis by controlling a pro-inflammatory pathway in macrophages
Yan, J. Y., Zhang, Y., Yu, H., Zong, Y., Wang, D., Zheng, J., Jin, L., Yu, X., Liu, C., Zhang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-34998-9 · Cited by 57
Obesity-induced neuroinflammation and cognitive impairment in young adult versus middle-aged mice
Henn, R. E., Elzinga, S. E., Glass, E., Parent, R., Guo, K., Allouch, A. M., Mendelson, F. E., Hayes, J., Webber‐Davis, I. F., Murphy, G. G., et al. (2022) · Immunity & Ageing · doi:10.1186/s12979-022-00323-7 · Cited by 61
“Others have similarly shown obesity induces an aging phenotype [34], particularly in adipose tissue [35].”
BackgroundDenk, D., Singh, A., Kasler, H. G., D’Amico, D., Rey, J., Alcober-Boquet, L., Gorol, J. M., Steup, C., Tiwari, R., Kwok, R., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00996-x · Cited by 63
“By protocol, no participants were excluded from final analysis, and analysis was performed by the original assigned group. concentrations of pro-inflammatory mediators favoring the development of heart disease and cancer 12,13 .”
Obesity and Pulmonary Hypertension
Ayinapudi, K., Singh, T., Motwani, A., Jemtel, T. H. L., & Oparil, S. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0899-2 · Cited by 64
Pîrsean, C., Negut, C. C., Staden, R. S., Dinu‐Pîrvu, C. E., Armean, P., & Udeanu, D. I. (2019) · PLoS ONE · doi:10.1371/journal.pone.0210288 · Cited by 57
Chu, Q., Jia, R., Chen, M., Li, Y., Yu, X., Wang, Y., Chen, W., Ye, X., Liu, Y., Jiang, Y., et al. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.09.039 · Cited by 53
Lam, B., Shrivastava, S. K., Shrivastava, A., Shankar, S., & Srivastava, R. K. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15413 · Cited by 61
Cheng, X., Ali, M. S. S. H., Moran, M., Viana, M. P., Schlichte, S. L., Zimmerman, M. C., Khalimonchuk, O., Feinberg, M. W., & Sun, X. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101863 · Cited by 57
SHP2 drives inflammation-triggered insulin resistance by reshaping tissue macrophage populations
Paccoud, R., Saint-Laurent, C., Piccolo, E. B., Tajan, M., Dortignac, A., Péreira, O., Gonidec, S. L., Baba, I., Gélineau, A., Askia, H., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abe2587 · Cited by 55
“Hyperactive SHP2 drives a metaflammation phenotype in NS mice It is recognized that low-grade inflammation of metabolic tissues can be present at the onset of glucose intolerance and insulin resistance during obesity as well as in chronic inflammatory disorders (16).”
BackgroundHepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
Kim, T. H., Hong, D.-G., & Yang, Y. M. (2021) · Biomedicines · doi:10.3390/biomedicines9121903 · Cited by 61
“Moreover, obesity-induced chronic inflammation, particularly in the liver, adipose tissue, and skeletal muscle, plays a crucial role in the development of local and systemic insulin resistance, simultaneously inducing a range of metabolic disturbances in multiple organs via inter-organ crosstalk [2,3].”
BackgroundB cell contribution to immunometabolic dysfunction and impaired immune responses in obesity
Oļeiņika, K., Šlisere, B., Catalán, D., & Rosser, E. C. (2022) · Clinical & Experimental Immunology · doi:10.1093/cei/uxac079 · Cited by 58
Li, N., Shi, H., Guo, Q., Gan, Y., Zhang, Y., Jia, J., Zhang, L., & Zhou, Y. (2022) · Nutrients · doi:10.3390/nu14183730 · Cited by 59
“Chronic inflammation plays a causal role in the development of IR [2,3], which is associated with a variety of tissues, including adipose tissue, skeletal muscle, liver, pancreas islet, and even the brain [4,5].”
BackgroundAli, R., Quinn, G. M., Umarova, R., Haddad, J. A., Zhang, G. Y., Townsend, E. C., Scheuing, L., Hill, K., Gewirtz, M. A., Rampertaap, S., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01273-y · Cited by 76
Arruda, A. P., Pers, B. M., Parlakgül, G., Güney, E., Goh, T., Cagampan, E., Lee, G. Y., Gonçalves, R. L. S., & Hotamışlıgil, G. S. (2017) · eLife · doi:10.7554/elife.29968 · Cited by 59
Immune–metabolic interactions during systemic and enteric infection in Drosophila
Lee, K., & Lee, W. (2018) · Current Opinion in Insect Science · doi:10.1016/j.cois.2018.05.014 · Cited by 52
Immunometabolism: Insights from the Drosophila model
Galenza, A., & Foley, E. (2019) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2019.01.011 · Cited by 59
Homeostatic and pathogenic roles of GM3 ganglioside molecular species in TLR4 signaling in obesity
Kanoh, H., Nitta, T., Go, S., Inamori, K., Veillon, L. J., Nihei, W., Fujii, M., Kabayama, K., Shimoyama, A., Fukase, K., et al. (2020) · The EMBO Journal · doi:10.15252/embj.2019101732 · Cited by 61
“Chronic inflammation plays critical roles in pathogenesis of a variety of human diseases, including metabolic disorders (Lumeng, 2011; Hotamisligil, 2017).”
Epigenetics and Inflammation in Diabetic Nephropathy
Shao, B., Zhang, S., Li, H.-D., Meng, X., & Chen, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.649587 · Cited by 58
“Studies have also shown that the modifications are reversible indicating potential therapeutic value for DN (Hotamisligil, 2017; Kato and Natarajan, 2019).”
BackgroundFerroptosis increases obesity: Crosstalk between adipocytes and the neuroimmune system
Zhang, S., Sun, Z., Jiang, X. Y., Lu, Z., Ding, L., Li, C., Tian, X., & Wang, Q. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1049936 · Cited by 62
“Under an inflammatory environment and oxidative stress, as obesity progresses, the increased secretion of pro-inflammatory cytokines and chemokines, such as monocyte chemotin-1, tumor necrosis factor (TNF) a, and interleukin (IL)-6, lead to a low-grade inflammatory response throughout the body (65).”
BackgroundInflammatory and immune etiology of type 2 diabetes
Blériot, C., Dalmas, É., Ginhoux, F., & Venteclef, N. (2023) · Trends in Immunology · doi:10.1016/j.it.2022.12.004 · Cited by 58
Glucocorticoid activation of anti-inflammatory macrophages protects against insulin resistance
Caratti, G., Stifel, U., Caratti, B., Jamil, A. J. M., Chung, K.-J., Kiehntopf, M., Gräler, M. H., Blüher, M., Rauch, A., & Tuckermann, J. P. (2023) · Nature Communications · doi:10.1038/s41467-023-37831-z · Cited by 48
Mitochondria: the gatekeepers between metabolism and immunity
Trinchese, G., Cimmino, F., Catapano, A., Cavaliere, G., & Mollica, M. P. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1334006 · Cited by 62
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
Morciano, C., Gugliandolo, S., Capece, U., Giuseppe, G. D., Mezza, T., Ciccarelli, G., Soldovieri, L., Brunetti, M., Avolio, A., Splendore, A., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02539-x · Cited by 57
Duarte, G. B. S., Reis, B. Z., Rogero, M. M., Vargas-Méndez, E., Barbosa, F., Cercato, C., & Cozzolino, S. M. F. (2019) · Nutrition · doi:10.1016/j.nut.2019.02.009 · Cited by 55
Yuenyongchaiwat, K., & Boonsinsukh, R. (2020) · Current Gerontology and Geriatrics Research · doi:10.1155/2020/8041489 · Cited by 60
“Additionally, a new concept regarding the mechanisms underlying sarcopenia is “metaflammation,” which has been described as a metabolic inflammation with metabolic diseases, such as diabetes mellitus and muscle mass [38, 39].”
BackgroundRu, X., Yang, L., Shen, G., Wang, K., Xu, Z., Bian, W., Zhu, W., & Guo, Y. (2024) · Frontiers in Chemistry · doi:10.3389/fchem.2024.1367395 · Cited by 58
“In fl ammation, the body ’ s natural defense against injury or infection, involves the activation of various immune cells, including macrophages, T cells, and B cells, accompanied by the production of cytokines (Hotamisligil, 2017).”
BackgroundKim, Y., Bayona, P. W., Kim, M., Chang, J., Hong, S., Park, Y., Budiman, A., Kim, Y. J., Choi, C. Y., Kim, W. S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00696 · Cited by 56
“In obesity, ATMs accumulate and are activated to produce high level of proinflammatory cytokines, which lead to adipose tissue inflammation and insulin resistance (5, 45).”
BackgroundWinn, N. C., Jurrissen, T. J., Grunewald, Z. I., Cunningham, R. P., Woodford, M. L., Kanaley, J. A., Lubahn, D. B., Manrique‐Acevedo, C., Rector, R. S., Vieira‐Potter, V. J., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00259.2018 · Cited by 52
Greendale, G. A., Huang, M., Cauley, J. A., Liao, D., Harlow, S. D., Finkelstein, J. S., Hans, D. B., & Karlamangla, A. S. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz056 · Cited by 55
Rhoads, T. W., Clark, J. P., Gustafson, G. E., Miller, K. N., Conklin, M. W., DeMuth, T. M., Berres, M. E., Eliceiri, K. W., Vaughan, L. K., Lary, C. W., et al. (2020) · Cell Systems · doi:10.1016/j.cels.2019.12.002 · Cited by 50
“This may be of particular importance for immune function and inflammatory tone, where there is extensive overlap in signaling through these pathways and those responsive to growth signals (Brestoff and Artis, 2015; Hotamisligil, 2017).”
BackgroundHigh‐fat diet‐induced adipose tissue expansion occurs prior to insulin resistance in C57BL/6J mice
He, M., Wang, J., Wang, Y., Sui, J., Zhang, M., Ding, X., Yang, Z., Chen, Z., Ren, X., & Shi, B. (2020) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2020.06.003 · Cited by 55
“Obesity is characterized by a chronic inflammation state initiated by excessive intake of food, especially overconsumption of high-energy processed foods that have abundant sugar and fat.(3) It has been proven that metabolic inflammation may impair insulin signaling in insulintargeted tissues and disrupt cellular meta…”
BackgroundSynthesis and anti-inflammatory activity of saponin derivatives of δ-oleanolic acid
Liu, L., Li, H., Hu, K., Xu, Q., Wen, X., Cheng, K., Chen, C., Yuan, H., Dai, L. X., & Sun, H. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112932 · Cited by 54
Du, X., Ma, X., Tan, Y., Shao, F., Li, C., Zhao, Y., Miao, Y., Han, L., Dang, G., Song, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01313-x · Cited by 52
“Immune system, as the main defense mechanism of the body, can be induced rapid adaptive response of metabolic remodeling in immune cells by immunogenic stimulation, and this process is called immune metabolism.(57) We have demonstrated that glucose metabolism and accumulation of phospholipids and fatty acids mediates…”
BackgroundTang, Y., Gao, Y., Nie, K., Wang, H., Shen, C., Su, H., Huang, W., & Dong, H. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.117829 · Cited by 54
Pentraxin 3 deficiency protects from the metabolic inflammation associated to diet-induced obesity
Bonacina, F., Moregola, A., Porte, R., Baragetti, A., Bonavita, E., Salatin, A., Grigore, L., Pellegatta, F., Molgora, M., Sironi, M., et al. (2019) · Cardiovascular Research · doi:10.1093/cvr/cvz068 · Cited by 51
Wei, Y., Gao, J., Kou, Y., Liu, M., Meng, L., Zheng, X., Xu, S., Ming, L., Sun, H., Liu, Z., et al. (2020) · The FASEB Journal · doi:10.1096/fj.201902900rr · Cited by 56
Huang, Z., Liang, N., Goñi, S., Damdimopoulos, A. E., Wang, C., Ballaire, R., Jager, J., Niskanen, H., Han, H., Jakobsson, T., et al. (2021) · Molecular Cell · doi:10.1016/j.molcel.2020.12.040 · Cited by 57
“…et al., 2012; Bonello et al., 2011; Bot et al., 2017; de Waard et al., 2010; Deshmane et al., 2009; Haringman et al., 2006; Hildebrand et al., 2013; Hotamisligil 2017; Kanda et al., 2006; Katakami et al., 2010; Kawano et al., 2016; Khyzha et al., 2019; Kulyté et al., 2014; Winter et al., 2018;…”
The Role of Mitochondrial Mutations and Chronic Inflammation in Diabetes
Dabravolski, S. A., Orekhova, V. A., Baig, M. S., Bezsonov, E. E., Starodubova, A. V., Попкова, Т. В., & Orekhov, A. N. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136733 · Cited by 59
“Low-level chronic inflammation is one of the main causes of obesity-induced insulin resistance and T2D development, especially in patients of older age [30].”
BackgroundMetformin-hydrogel with glucose responsiveness for chronic inflammatory suppression
Zheng, D., Chen, W., Ruan, H., Cai, Z., Chen, X., Chen, T., Zhang, Y., Cui, W., Chen, H., & Shen, H. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.131064 · Cited by 49
KLF10 Deficiency in CD4+ T Cells Triggers Obesity, Insulin Resistance, and Fatty Liver
Wara, A. K., Wang, S., Wu, C., Fang, F., Haemmig, S., Weber, B. N., Aydogan, C. O., Tesmenitsky, Y., Aliakbarian, H., Hawse, J. R., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108550 · Cited by 49
“Obesity is accompanied by a high risk of insulin resistance and type 2 diabetes, which are major threats to global human health (Hotamisligil, 2006, 2017; Lee et al., 2018; Yamauchi and Kadowaki, 2013).”
Kavyani, Z., Najafi, K., Naghsh, N., Karvane, H. B., & Musazadeh, V. (2024) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2024.106867 · Cited by 52
Mohaghegh, N., Ahari, A. F., Buttles, C., Davani, S., Hoang, H., Huang, Q., Huang, Y., Hosseinpour, B., Abbasgholizadeh, R., Cottingham, A. L., et al. (2024) · ACS Nano · doi:10.1021/acsnano.4c10742 · Cited by 51
Jiao, B., An, C., Du, H., Tran, M., Yang, D., Zhao, Y., Wang, P., Hu, Z., Zhou, D. F., & Wang, Y. (2025) · British Journal of Pharmacology · doi:10.1111/bph.17412 · Cited by 50
“Chronic inflammation develops when the initial injury is severe or persistent, resulting in a continued expression of inflammatory molecules, which can cause tissue damage, fibrosis and ultimately lead to organ dysfunction (Hotamisligil, 2017; Suthahar et al., 2017; Wynn & Ramalingam, 2012).”
Sharma, M., & Sharma, R. (2018) · RSC Advances · doi:10.1039/c7ra13555f · Cited by 48
Santoro, A., Guidarelli, G., Ostan, R., Giampieri, E., Fabbri, C., Bertarelli, C., Nicoletti, C., Kadi, F., de Groot, L. C. P. G. M., Feskens, E., et al. (2019) · European Radiology · doi:10.1007/s00330-018-5973-2 · Cited by 47
“Metabolic diseases are character ized by an inf lammatory status cal led metaflammation, a particular case of chronic inflammation driven by nutrient excess/overnutrition [8].”
BackgroundMetabolic Inflammation in Obesity—At the Crossroads between Fatty Acid and Cholesterol Metabolism
Curley, S., Gall, J., Byrne, R., Yvan‐Charvet, L., & McGillicuddy, F. C. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201900482 · Cited by 51
Soluble mannose receptor induces proinflammatory macrophage activation and metaflammation
Embgenbroich, M., van der Zande, H. J. P., Hussaarts, L., Schulte-Schrepping, J., Pelgrom, L. R., García‐Tardón, N., Schlautmann, L., Stötzel, I., Händler, K., Lambooij, J. M., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103304118 · Cited by 52
“Macrophage reprogramming towards an inflammatory phenotype plays a critical role in obesity-induced metaflammation (Lackey and Olefsky, 2016; Hotamisligil, 2017).”
BackgroundSuzzi, S., Croese, T., Ravid, A., Gold, O., Clark, A. R., Medina, S., Kitsberg, D., Adam, M., Vernon, K. A., Kohnert, E., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36759-8 · Cited by 50
Inflammation in individuals with schizophrenia – Implications for neurocognition and daily function
Kogan, S., Ospina, L. H., & Kimhy, D. (2018) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2018.09.016 · Cited by 52
Immune Regulation of Metabolic Homeostasis by Helminths and Their Molecules
van der Zande, H. J. P., Zawistowska‐Deniziak, A., & Guigas, B. (2019) · Trends in Parasitology · doi:10.1016/j.pt.2019.07.014 · Cited by 52
Gong, Z., Zhang, X., Su, K., Jiang, R., Sun, Z., Chen, W., Forno, E., Goetzman, E. S., Wang, J., Dong, H. H., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-04983-x · Cited by 52
“Substantial evidence links obesity and chronic inflammation [5].”
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
Torre, P., Motta, B. M., Sciorio, R., Masarone, M., & Persico, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.781567 · Cited by 53
“Prolonged, unresolved, and low-grade inflammation gets no advantage to the host (149), and in NAFLD it causes the onset of scars responsible for liver cirrhosis.”
BackgroundLi, K., Yuan, M., Wu, Y., Pineda, M. A., Zhang, C., Chen, Y., Chen, Z., Rong, X., Turnbull, J. E., & Guo, J. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100950 · Cited by 49
MANF: an emerging therapeutic target for metabolic diseases
Tang, Q., Li, Y., & He, J. (2022) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2022.01.001 · Cited by 49
“Effect of MANF on inflammation Chronic low-grade inflammation plays a key role in the initiation, propagation, and development of metabolic diseases [46].”
BackgroundAdipocyte GPX4 protects against inflammation, hepatic insulin resistance and metabolic dysregulation
Schwärzler, J., Mayr, L., Radlinger, B., Grabherr, F., Philipp, M., Texler, B., Grander, C., Ritsch, A., Hunjadi, M., Enrich, B., et al. (2022) · International Journal of Obesity · doi:10.1038/s41366-022-01064-9 · Cited by 57
“Systemic inflammation not only develops as a by-stander of metabolic disorders but contributes to disease progression by impairing insulin signalling and lipid metabolism [5].”
Backgrounddos Santos, D. M. C., Rejeski, K., Winkelmann, M., Liu, L., Trinkner, P., Günther, S., Bücklein, V., Blumenberg, V., Schmidt, C., Kunz, W. G., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.280189 · Cited by 53
“Basic data Age in years, median (range) Female patients, N (%) 61 (19-82) 23 (35.”
BackgroundFélix, F. B., Vago, J. P., Beltrami, V. A., Araújo, J. M. D., Grespan, R., Teixeira, M. M., & Pinho, V. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106246 · Cited by 47
Nurcahyanti, A., Cokro, F., Wulanjati, M., Mahmoud, M. F., Wink, M., & Sobeh, M. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.891339 · Cited by 38
“Some molecular pathways of inflammation and obesity are cross-talked with insulin resistance and diabetes (42, 43).”
BackgroundXie, Y., Kuang, W., Wang, D., Yuan, K., & Yang, P. (2023) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2023.115175 · Cited by 53
Distinct adipose progenitor cells emerging with age drive active adipogenesis
Wang, G., Li, G., Song, A., Zhao, Y., Yu, J., Wang, Y., Dai, W., Salas, M. C., Qin, H., Medrano, L. J., et al. (2025) · Science · doi:10.1126/science.adj0430 · Cited by 57
Gene Therapy Strategies to Restore ER Proteostasis in Disease
Valenzuela, V., Jackson, K. L., Sardi, S. P., & Hetz, C. A. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.04.004 · Cited by 56
“Metabolic Disorders ER stress has been proposed as a central pathological event linked to insulin resistance and obesity.(94,95) Aberrant lipidmetabolism disrupts calcium homeostasis, causing liver ER stress in obesity.”
BackgroundMetcalfe, A. J., Koliamitra, C., Javelle, F., Bloch, W., & Zimmer, P. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.07.015 · Cited by 52
Numaguchi, R., Furuhashi, M., Matsumoto, M., Sato, H., Yanase, Y., Kuroda, Y., Harada, R., Ito, T., Higashiura, Y., Koyama, M., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011147 · Cited by 48
“Several bioactive molecules derived from adipose tissue, adipokines, have been implicated in the increased risk of atherosclerotic cardiovascular disease.(1,2) Adiponectin, a favorable adipokine, has been shown to modulate macrophage function in the direction of an anti-inflammatory phenotype.”
BackgroundRegulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC
John, B. A., Naczki, C., Patel, C. M., Ghoneum, A., Qasem, S. A., Salih, Z. T., & Said, N. A. (2019) · Oncogene · doi:10.1038/s41388-019-0728-3 · Cited by 55
Hepatoprotective effect of chlorogenic acid against chronic liver injury in inflammatory rats
Chen, Z., Yang, Y., Mi, S., Fan, Q., Sun, X., Deng, B., Wu, G., Li, Y., Zhou, Q., & Ruan, Z. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103540 · Cited by 48
Wang, L., Zhao, R., Song, X., & Wu, W. (2019) · Scientific Reports · doi:10.1038/s41598-019-52265-8 · Cited by 51
Regulation of inflammation in diabetes: From genetics to epigenomics evidence
Diedisheim, M., Carcarino, E., Vandiedonck, C., Roussel, R., Gautier, J., & Venteclef, N. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101041 · Cited by 51
Approaching Inflammation Paradoxes—Proinflammatory Cytokine Blockages Induce Inflammatory Regulators
Liu, M., Saredy, J., Zhang, R., Shao, Y., Sun, Y., Yang, W. Y., Wang, J., Liu, L., Drummer, C., Johnson, C., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.554301 · Cited by 49
“It has been documented that inflammation and metaflammation are evolutionally conserved; the underlying pathways are crosstalking (48).”
Background
Metadata
- Authors
- Hotamisligil, G. S.
- Venue
- Nature
- Published
- 2017-02-09
- Volume
- 542
- Issue
- 7640
- Pages
- 177-185
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2587680743
- Cited by
- 2,570
- References
- 144
- Citations by year
- 2026: 501 · 2025: 322 · 2024: 264 · 2023: 253 · 2022: 252 · 2021: 296 · 2020: 283 · 2019: 217 · 2018: 125 · 2017: 57
- FWCI
- 24.74
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institute for Health and Care Research
- Servier
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL125753)
- National Institute of Allergy and Infectious Diseases (R01AI116901)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK052539)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- inflammation, metabolic inflammation, immunometabolism, obesity, metabolic disorders, adipose tissue inflammation, non-communicable diseases, diabetes mellitus
- MeSH terms
- Animals, Clinical Trials as Topic, Hormones, Humans, Inflammation, Invertebrates, Metabolic Diseases, Obesity, Organelles, Signal Transduction, Cytokines, Evolution, Molecular, Genome-Wide Association Study, Adaptive Immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.